Aurobindo Pharma said that it received final approval from US FDA for two ANDAs namely Cefotaxime for injection USP 500 mg, 1 g, 2 g and Cefotaxime for injection USP of 10g pharmacy bulk pack.
Cefotaxime injection is generic equivalent to Claforan injection of Sanofi Aventis U. S. LLC. Cefotaxime injection falls under the anti-betallactum segment and is ready for launch.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.